The Halal Deadline Hiding Inside Your Content Calendar

October 17, 2026 is a content deadline, not just a regulatory one. Natural medicines, quasi-drugs, health supplements, cosmetics, and Class A medical devices must carry BPJPH's new halal certification and its "Gunungan" logo by that date, replacing the old MUI mark entirely. Any product page still showing uncertified status, or the retired logo, after that date is simultaneously a BPOM compliance gap and a Google Trustworthiness problem, and the two systems will flag it independently of each other.

Most content calendars are built around campaigns and seasonal topics, Ramadan tie-ins, year-end promotions, new product launches. This deadline doesn't care about either, and it doesn't pause for a campaign that was planned before the certification requirement became urgent.

What Changes, and When

BPJPH's certification rollout under Government Regulation 42/2024 is staggered by product risk category, and the first deadline is closer than most content teams have planned for. Missing it isn't a distant compliance risk, it's a change that takes effect on a specific, already-set date.

Deadline	Category
17 October 2026	Natural medicines, quasi-drugs, health supplements, cosmetics, Class A medical devices
17 October 2029	OTC and limited OTC drugs
17 October 2034	Prescription drugs, excluding psychotropics
17 October 2039	Biological products, Class D medical devices

The Halal Deadline Sits on Top of a Regulatory Framework That's Already Moving Fast

BPOM has revised its online drug sale rules three times in roughly eighteen months, which means a content team treating any single regulation as settled is working from a document that may already be superseded. Regulation No. 14/2024 established the initial online drug sale framework. Regulation No. 30/2025, signed October 22, 2025 and effective November 3, 2025, was the third revision, requiring valid market authorization numbers on all online listings and giving marketplace operators responsibility for removing non-compliant listings on notice. Regulation No. 7/2026, effective April 16, 2026, expanded the drug promotion and advertising framework and superseded the prior advertising regulation entirely.

The practical distinction that survives across all three revisions: prescription drugs, Obat Keras, may only be promoted to medical and health professionals through scientific media, never to the general public. Over-the-counter drugs may be advertised publicly, but require BPOM pre-approval, must be in Bahasa Indonesia, and must be objective and non-misleading. Content in online media and social media is permitted, but only within the approved ad copy, and two-way interaction features on social platforms don't create an exception to that boundary. A content calendar that treats "pharma content" as one category rather than splitting by this distinction will eventually publish something that isn't legally allowed to exist.

Jamu Occupies Its Own Claims Tier, Separate From the Halal Deadline

Traditional medicine sits in a content grey area that's easy to get wrong in a different direction than the halal certification issue. BPOM classifies traditional and herbal products into three tiers, each with a different ceiling on what a page is allowed to claim.

Category	What the Page Can Claim
Obat Tradisional	Traditional use only, no clinical efficacy claim for a specific condition
Obat Herbal Terstandarisasi (OHT)	Standardised composition, backed by preliminary clinical evidence
Fitofarmaka	Full clinical trial data, evidence-based claims equivalent to pharmaceuticals

A 2025 systematic literature review of 30 studies found that knowledge of jamu's benefits, safety perception, and social media exposure significantly influenced Generation Z's interest in consuming traditional medicine, with digital marketing and product innovation confirmed as effective ways to reach younger consumers. That's a real, growing audience. The content risk is positioning an Obat Tradisional product as though it were a Fitofarmaka, borrowing the confident, specific claims that only the highest evidence tier is allowed to make. That mismatch is both a BPOM compliance issue and, separately, a Google YMYL misleading-content issue, since the two systems flag the same kind of overreach for different reasons.

The Other Deadline Nobody's Content Calendar Accounts For

UU PDP, Indonesia's Personal Data Protection Law, has been fully enforceable since October 2024, and healthcare content teams building appointment forms and symptom checkers are still catching up. Health data collected through any form, chatbot, or symptom tool counts as Specific Personal Data, a heightened category requiring explicit, granular, withdrawable consent, not a bundled checkbox buried in terms of service.

A 2025 academic review found more than 60% of Indonesian companies had not yet fully complied with UU PDP, more than a year after it became fully enforceable. The stakes aren't abstract, 279 million BPJS Kesehatan records were leaked in 2021, along with 6 million patient records from a Ministry of Health server. Beyond consent and breach notification, the law also restricts cross-border transfer of personal data to countries without equivalent protection, relevant for any hospital group using an overseas-hosted booking platform or analytics tool, and requires a designated Data Protection Officer for organizations conducting large-scale health data processing. None of these are optional add-ons to a privacy policy template, they're distinct, separately enforceable obligations.

Auditing an Existing Content Calendar Against Both Deadlines

Most content calendars weren't built with either deadline in mind, which means the practical starting point is an audit rather than a rewrite from scratch. For halal certification, that means pulling every live product page in the affected categories, natural medicines, quasi-drugs, supplements, cosmetics, and Class A devices, and checking three things: whether the certification status shown matches BPJPH's actual record, whether any imagery still carries the old MUI logo, and whether products with no certification path at all now need the non-halal declaration instead of silence.

For UU PDP, the audit runs through every form, chatbot, and symptom tool on the site, checking whether consent is genuinely granular and separate from general terms of service, whether a breach-notification process actually exists rather than being assumed, and whether any data flows to an overseas server or third-party tool that hasn't been evaluated against the cross-border transfer restriction. Neither audit is a one-time project. Both deadlines, and the jamu tier system alongside them, need a recurring review slot on the same content calendar they're auditing, since BPOM alone has changed the underlying framework three times in eighteen months.

---

Frequently Asked Questions

Does the halal deadline apply to hospitals, or only pharma and supplement brands?

Directly, it applies to the product categories listed, natural medicines, quasi-drugs, supplements, cosmetics, and Class A devices. A hospital pharmacy or gift shop selling any of these products is still affected even if the hospital itself isn't a manufacturer.

What should a product page show while certification is still in progress?

Honest, current status, not a claim of completion. Update the page the moment certification is confirmed, and remove any old MUI-logo imagery in the meantime rather than leaving it as a default.

Is BPJS Kesehatan data covered by UU PDP the same way as private clinic data is?

Health data is Specific Personal Data under UU PDP regardless of whether it sits with a public insurance scheme or a private provider. The 2021 breach of 279 million BPJS Kesehatan records is exactly the kind of exposure the law's breach-notification requirement is meant to address going forward.

Do symptom checkers count as automated decision-making under UU PDP?

A symptom checker that generates a recommendation based on user input plausibly falls under the law's provisions on automated decisions, which carry a data subject's right to object. Treating it conservatively, with clear consent and an easy human-review path, is the defensible position pending clearer regulatory guidance.

What's the actual penalty for missing the halal certification deadline?

BPOM has administrative action authority, including listing removal, for products found non-compliant after the deadline. The bigger practical risk for most brands is market access itself, an uncertified product simply cannot legally remain on shelf or online after the date it was due.

Can a jamu brand claim it "helps with" a specific condition on its product page?

Only if it's certified as a Fitofarmaka with the clinical trial data to back that specific claim. An Obat Tradisional or OHT product making the same condition-specific claim is overstating its tier, a BPOM compliance issue and a Google YMYL misleading-content issue at the same time.

Does UU PDP apply differently to a hospital using an overseas-hosted booking system?

Yes, that's exactly the scenario the cross-border transfer restriction addresses. Data flowing to a jurisdiction without equivalent protection needs its own legal basis, which a standard consent checkbox on a booking form does not automatically satisfy.

How often does the BPOM advertising framework actually change?

Three revisions in roughly eighteen months as of this research cycle, Regulation 14/2024, 30/2025, and 7/2026. Treating any single version as permanently settled is a real operational risk, check the current regulation number before assuming an existing content calendar is still compliant.

The full regulatory and compliance roadmap for GEO and content programmes operating across BPOM, BPJPH, and UU PDP simultaneously is covered in Cited or Silent. The free chapter is at arfadia.com/resources/ebook-cited-or-silent, also on Amazon, Google Play Books, and Apple Books.

Pharma and supplement brands auditing their content against both deadlines can start with the compliance review inside our Healthcare SEO service.

---